Loading stock data…
McKesson Corporation (MCK)
N/A
McKesson Corporation provides healthcare services in the United States and internationally.
Historical Price
No chart data available for MCK
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $96.30B↓ | $106.16B↑ | $103.15B↑ | $97.83B↑ | $90.82B |
| Gross Profit | $4.04B↑ | $3.69B↑ | $3.54B↑ | $3.28B↓ | $3.64B |
| Operating Income | $2.25B↑ | $1.66B↑ | $1.47B↑ | $1.08B↓ | $1.66B |
| Net Income | $1.68B↑ | $1.19B↑ | $1.11B↑ | $784.00M↓ | $1.26B |
Peer Comparison
JNJUNHPFE
Fundamentals
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$87.88B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-219.24%
Volume
Today's trading volume
-
Recent News
Is McKesson Corporation (MCK) A Good Stock To Buy Now?
Is MCK a good stock to buy? We came across a bullish thesis on McKesson Corporation on r/ValueInvesting by OnTheStreetwithLou. In this article, we will summarize the bulls’ thesis on MCK. McKesson Corporation’s share was trading at $763.91 as of June 23rd. MCK’s trailing and forward P/E were 19.41 and 16.81 respectively according to Yahoo Finance. McKesson […]
3 Reasons We Love McKesson (MCK)
Over the past six months, McKesson’s shares (currently trading at $763.33) have posted a disappointing 8.1% loss, well below the S&P 500’s 6.8% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.